Onconetix, Inc. (ONCO) stock
ONCONasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.21+0.18 (+5.94%)
Close on Nov 13, 2026Market cap $12.68MP/E –Yield –
Onconetix profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Onconetix's profit margin for the twelve months ending Sep 30, 2026 was -7423.9%. For fiscal 2025 it was -1721.0%, against -2325.2% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -1721.0% | +604.2 |
| FY2024 | Dec 31, 2024 | -2325.2% | +61661.3 |
| FY2023 | Dec 31, 2023 | -63986.5% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -30741.4% | −27848.7 |
| Q2 FY2026 | Jun 30, 2026 | -16748.3% | −14520.5 |
| Q1 FY2026 | Mar 31, 2026 | -19643.4% | −11234.5 |
| Q4 FY2025 | Dec 31, 2025 | 1867.5% | +6002.2 |
| Q3 FY2025 | Sep 30, 2025 | -2892.7% | −1952.0 |
| Q2 FY2025 | Jun 30, 2025 | -2227.8% | −198.0 |
| Q1 FY2025 | Mar 31, 2025 | -8408.8% | −6821.4 |
| Q4 FY2024 | Dec 31, 2024 | -4134.7% | – |
| Q3 FY2024 | Sep 30, 2024 | -940.7% | – |
| Q2 FY2024 | Jun 30, 2024 | -2029.8% | – |
| Q1 FY2024 | Mar 31, 2024 | -1587.4% | – |
See a number that looks wrong?